Literature DB >> 2413373

In vivo and in vitro actions of mammalian tachykinins.

U Holzer-Petsche, E Schimek, R Amann, F Lembeck.   

Abstract

Recently, two kassinin-like tachykinins have been isolated from mammalian nervous tissue. The potencies of these peptides, substance K (neurokinin alpha) and neuromedin K (neurokinin beta) were compared with those of substance P, eledoisin, and kassinin in various pharmacological systems in vivo and in vitro. In contracting the isolated guinea-pig ileum and rabbit jejunum the potencies of eledoisin, kassinin, substance K, and neuromedin K were 13-80% that of substance P. In the rat vas deferens substance K and neuromedin K potentiated the electrically induced contractions with potencies similar to those of eledoisin and kassinin; they were 46-236 times as potent as substance P. In stimulating salivation in the rat after intravenous injection, eledoisin, kassinin, and substance K were respectively 2.3, 1.3 and 0.33 times as potent as substance P. In contrast, neuromedin K exhibited negligible activity. Each peptide tested led to a short fall in blood pressure after intravenous injection in the rabbit, substance P being 12-250 times as potent as the other peptides. Substance P was 20 times as potent as substance K or neuromedin K in inducing vasodilatation in the rat hind paw in vivo. Of the peptides tested, only substance P (10 nmol/min) significantly increased the release of histamine from the rat isolated hindquarter preparation. The results are discussed with respect to several theories of tachykinin receptor heterogeneity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413373     DOI: 10.1007/bf00499905

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  31 in total

1.  An unidentified depressor substance in certain tissue extracts.

Authors:  U S V Euler; J H Gaddum
Journal:  J Physiol       Date:  1931-06-06       Impact factor: 5.182

2.  Release of histamine by substance P.

Authors:  F Erjavec; F Lembeck; T Florjanc-Irman; G Skofitsch; J Donnerer; A Saria; P Holzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-08       Impact factor: 3.000

3.  Pharmacological characterization of four related substance P antagonists.

Authors:  U Björkroth; S Rosell; J C Xu; K Folkers
Journal:  Acta Physiol Scand       Date:  1982-10

4.  The role of the N-terminal tetrapeptide in the histamine releasing action of substance P.

Authors:  N Mazurek; I Pecht; V I Teichberg; S Blumberg
Journal:  Neuropharmacology       Date:  1981-11       Impact factor: 5.250

5.  Pharmacological characterisation of a novel tachykinin isolated from mammalian spinal cord.

Authors:  J C Hunter; J E Maggio
Journal:  Eur J Pharmacol       Date:  1984-01-13       Impact factor: 4.432

6.  Potentiation of tachykinin-induced plasma protein extravasation by calcitonin gene-related peptide.

Authors:  R Gamse; A Saria
Journal:  Eur J Pharmacol       Date:  1985-08-07       Impact factor: 4.432

7.  Rapid degradation of [3H]-substance p in guinea-pig ileum and rat vas deferens in vitro.

Authors:  S P Watson
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

8.  The pharmacological profile of a substance P (SP) antagonist. Evidence for the existence of subpopulations of SP receptors.

Authors:  S Rosell; U Björkroth; J C Xu; K Folkers
Journal:  Acta Physiol Scand       Date:  1983-03

9.  Histamine in tissue: determination by high-performance liquid chromatography after condensation with o-phthaldialdehyde.

Authors:  G Skofitsch; A Saria; P Holzer; F Lembeck
Journal:  J Chromatogr       Date:  1981-11-13

10.  Substance K: a novel mammalian tachykinin that differs from substance P in its pharmacological profile.

Authors:  H Nawa; M Doteuchi; K Igano; K Inouye; S Nakanishi
Journal:  Life Sci       Date:  1984-03-19       Impact factor: 5.037

View more
  7 in total

1.  CP-96,345, a non-peptide antagonist of substance P: I. Effects on the actions mediated by substance P and related tachykinins on the guinea-pig ileum and rabbit jejunum.

Authors:  F J Legat; T Griesbacher; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

2.  Effects of tachykinins on myenteric neurones of the guinea-pig gastric corpus: involvement of NK-3 receptors.

Authors:  M Schemann; H Kayser
Journal:  Pflugers Arch       Date:  1991-12       Impact factor: 3.657

3.  Substance P modulates the release of locally synthesized nerve growth factor from rat saphenous nerve neuroma.

Authors:  D M White; P Ehrhard; M Hardung; D K Meyer; M Zimmermann; U Otten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-11       Impact factor: 3.000

4.  Tachykinins influence interdigestive rhythm and contractile strength of human small intestine.

Authors:  M Lördal; E Theodorsson; P M Hellström
Journal:  Dig Dis Sci       Date:  1997-09       Impact factor: 3.199

5.  CP-96,345, a non-peptide antagonist of substance P: II. Actions on substance P-induced hypotension and bronchoconstriction, and on depressor reflexes in mammals.

Authors:  T Griesbacher; J Donnerer; F J Legat; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

6.  Plasma protein extravasation induced by mammalian tachykinins in rat skin: influence of anaesthetic agents and an acetylcholine antagonist.

Authors:  R Couture; R Kérouac
Journal:  Br J Pharmacol       Date:  1987-06       Impact factor: 8.739

7.  Highly selective agonists for substance P receptor subtypes.

Authors:  U Wormser; R Laufer; Y Hart; M Chorev; C Gilon; Z Selinger
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.